Why We Shouldn’t Trade a Weakened FDA for More Medical Research Funds

STAT, May 17, 2016. There is no question that more research funding is necessary and that finding legitimate ways to get medicines to patients faster is crucial. But Congress ought to separate the debate over research funding from the rest of the legislation. Loosening regulatory standards would only create problems for which real cures will be needed.

Read More »

Experts Decry Tying Medical Research Funds to FDA Standards Changes

Wall Street Journal, May 12, 2016. Moves in Congress to link billions of dollars in new medical research funding to revised standards for drug and medical-device approvals are troubling some public-health experts, who say the combination makes it too easy for lawmakers to support lower patient-safety standards.

Read More »